NCT06960876 Comparative Effects of Therapeutic Ultrasound and Sinus Massage in Chronic Rhinosinusitis: a Randomized Controlled Study
| NCT ID | NCT06960876 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Chronic Rhinosinusitis (CRS) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-07-18 |
| Primary Completion | 2025-06-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-07-18 with a primary completion date of 2025-06-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized controlled trial. Previous studies show that both therapeutic ultrasound and sinus massage techniques have significant results in Chronic Rhinosinustis (CRS). However, there is no comparative study carried out between these two to show which technique has more effects in CRS. This study will determine their comparative effects on: 1. Pain measured on Numerical pain rating scale 2. Sinonasal symptoms measured on sino-nasal outcome test questionaire 3. Quality of life measured on rhinosinusitis disability index (RSDI) 4. Nasal inspiratory airflow measured on peak nasal inspiratory flow meter. Participants of chronic rhinosinusitis will be selected according to the diagnostic criteria of American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) and will be randomly allocated into three groups. All three group will continue to receive medical intervention. Additionally one group will receive therapeutic ultrasound while other group will receive sinus massage. Whereas third group will be control group and won't receive any additional treatment. Data will be collected at Foundation University College of Physical Therapy and Fauji Foundation Hospital.
Eligibility Criteria
Inclusion Criteria: * Age 20-60 years * Both gender * Diagnosed patients of chronic rhinosinusitis referred by an ENT specialist * According to the AAO-HNS, patients are diagnosed with CRS if they had: * Two or more major symptoms for ≥12 weeks. Or * one major symptom with two minor symptoms for ≥12 weeks (19) Major clinical symptoms * Pain or pressure on the face * Nasal congestion * Mucopurulent rhinorrhea either anteriorly, posteriorly, or both * Hyposmia/anosmia Minor clinical symptoms * Headache * Fever * Pain in the dental area * Halitosis * Pain or pressure on the ear * Cough Exclusion Criteria: * Nasal polyps * Current Medical conditions in which ultrasound is contraindicated (20) * Facial metal implants * Face or head tumor/cyst/malignancy * Deteriorated cognitive level * Previous surgery on the nose * Facial bone fracture * Reduced heat perception * Ischemic tissues * Skin allergies/lesions to the face
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06960876 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Chronic Rhinosinusitis (CRS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06960876 currently recruiting?
Yes, NCT06960876 is actively recruiting participants. Contact the research team at amnasheroz4322@gmail.com for enrollment information.
Where is the NCT06960876 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT06960876 clinical trial?
NCT06960876 is sponsored by Foundation University Islamabad. The trial plans to enroll 60 participants.